期刊
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
卷 11, 期 4, 页码 425-444出版社
TAYLOR & FRANCIS AS
DOI: 10.1586/ERM.11.18
关键词
cancer; exome; fusion genes; genetics; massively parallel sequencing; mutations; third-generation sequencing
类别
资金
- Breakthrough Breast Cancer charity
- Breakthrough Breast Cancer
Next-generation sequencing technologies have begun to revolutionize the field of cancer genetics through rapid and accurate assessment of a patient's DNA makeup with minimal cost. These technologies have already led to the realization of the inter- and intra-tumor genetic heterogeneity and the identification of novel mutations and chimeric genes, however, several challenges lie ahead. Given the low number of recurrent somatic genetic aberrations in common types of cancer, the identification of 'driver' genetic aberrations has proven challenging. Furthermore, implementation of next-generation sequencing and/or some of its derivatives into routine practice as diagnostic tests will require in-depth understanding of the pitfalls of these technologies and a great degree of bioinformatic expertise. This article focuses on the contribution of next-generation sequencing technologies to diagnosis and cancer prognostication and prediction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据